Human Longevity's $599 Genomics for All: What Clinical-Grade DNA Sequencing Gets You Now
Human Longevity sequences all 6.4 billion base pairs at $599 — and an AI layer re-alerts you as science evolves. What it covers, who it's actually for, and why the re-analysis matters more than the price.
Your Complete Genome for $599: Human Longevity Inc. Bets on Consumer Genomics
Human Longevity Inc. now offers full whole-genome sequencing for $599 — down from ~$10,000 a decade ago — bundled with AI-powered multi-omics analysis across more than 50,000 conditions.
The Breast Cancer Screening Framework Peter Attia Uses — And Why Standard Mammogram Advice Falls Short
Risk-stratified screening starts with a formal risk assessment by age 25 — not when your doctor first orders a mammogram at 40. Peter Attia's framework explains why, and what the implementation failure actually looks like at scale.
4 Genetic Tests Worth Getting — And Why Most Aren't
Peter Attia's Episode #392 framework on genetic testing: the four high-penetrance tests that actually change clinical decisions, and why most DTC tests don't.
APOE2: The Gene That Supercharges Your Neurons' DNA Repair
Buck Institute research links APOE2 to measurably lower neuronal senescence and stronger DNA repair — the mechanism behind why APOE2 carriers resist Alzheimer's disease.
Peter Attia AMA #84: Family History, NAD Skepticism, and Dementia Risk
Peter Attia AMA #84: why family health history outperforms genetic testing, his stance on NAD supplements, and minimum effective strength training dose.